García SD, Rodríguez JBL, Díaz CJC

Language: Spanish
References: 0
Page: 201-212
PDF size: 160.83 Kb.

ABSTRACT

Introduction: there is currently an immune response against cancer initiated by signals transmitted by the tumor cell. Method: a bibliographic review was carried out to develop a reflexive critical analysis of the content of documents published from 2005 to 2016. Objective: to propose an update on the subject. Development: immunotherapy is a pillar of fundamental treatment, the most used in this group has been the monoclonal antibodies. With the advancement of science and the deepening of studies, the specificity, efficacy and safety of the new drug groups have been perfected and novel pathways have emerged as a molecular target. Conclusions: the route covered by immunotherapy has become, for modern Oncology, a powerful instrument that has considerably improved the life expectancy of patients suffering from malignant diseases.